71 results
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
Incentive Plan and our 2011 Equity Incentive Plan, with a weighted-average exercise price of $10.33 per share; and
988,792 shares reserved … for future issuance under our 2020 Equity Incentive Plan.
Unless otherwise indicated, all information in this prospectus supplement (i) excludes Private
8-K/A
xpqz37m65b uiu5
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
8-K/A
EX-99.1
3e0v 6a99srr
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
424B5
ya44z3vwkqyt1cw
1 Feb 24
Prospectus supplement for primary offering
4:49pm